Search

  • English (Anglais)
  • Français
  • Italiano (Italien)
  • Português (Portugais)
  • Español (Espagnol)

Recent Highlights

Recent Posts

  • Ezequiel A. Camerini, David C. Camerini and Tomas M. Casalins, participated in a Spanish-language web conference organized by CEDEFLaw/Masterlaw titled “Trusts in the U.S.” P. Augusto Van Thienen, CEO & Co-Founder of Instituto CEDEFLaw, moderated the event.
  • Many businesses financially impacted by the COVID-19 outbreak have been pushing the insurance industry to cover their income losses under business interruption insurance, even when their insurance contracts omit pandemics as the triggering event
  • Some time ago a U.S. businessman leaned across the lunch table and asked me in confidential tones what “equity” meant in contract phrases like “claims arising in law or in equity.”
  • One of our founders, Donald T. Fox was included in The American Law Institute’s (ALI) series on its Life Members
  • David Camerini and Tomás María Casalins publish article in the Chilean newspaper El Mercurio Legal

Recent Posts

  • Ezequiel A. Camerini, David C. Camerini and Tomas M. Casalins, participated in a Spanish-language web conference organized by CEDEFLaw/Masterlaw titled “Trusts in the U.S.” P. Augusto Van Thienen, CEO & Co-Founder of Instituto CEDEFLaw, moderated the event.
  • Many businesses financially impacted by the COVID-19 outbreak have been pushing the insurance industry to cover their income losses under business interruption insurance, even when their insurance contracts omit pandemics as the triggering event
  • Some time ago a U.S. businessman leaned across the lunch table and asked me in confidential tones what “equity” meant in contract phrases like “claims arising in law or in equity.”
  • One of our founders, Donald T. Fox was included in The American Law Institute’s (ALI) series on its Life Members
  • David Camerini and Tomás María Casalins publish article in the Chilean newspaper El Mercurio Legal
  • PPP Vigilance
  • Donald T. Fox Contributes to NYCBA 150th Anniversary Celebration
  • NOVEL IMPACT? COVID-19 AND FORCE MAJEURE PROVISIONS
  • CLIENT ALERT
  • COVID-19 and The Government Incentives
  • EMBRAPII Event at Cornell Tech
  • Fox Horan & Camerini Co-Sponsors with Golden Hawk Consulting Asia-Brazil Networking Event
  • Commemoration of 50th Anniversary
  • David Camerini Speaks About Startups at 3SPIN Summit Brazil 2018
  • The firm advised HC Corporation Argentina in the acquisition of Staples’ Argentine subsidiary.
  • David C. Camerini and Tomas M. Casalins publish article in “Abogados-inhouse.com” titled (as translated) “Criminal Liability Regime Applicable to Companies, and the Opportunity to Create a Compliance Program to be Effective in Several Jurisdictions
  • The firm represented Mercon Coffee Group in several credit transactions
  • The firm represented Mr. Demir Sabanci and Sedes Holdings A.Ş. in the sale of the controlling participation of Gratis İç ve Dış Ticaret A.Ş.
  • The firm represented Laboratorios Elea in the purchase of Laboratorios Phoenix in Argentina
  • David C. Camerini and Tomas M. Casalins gave a presentation in Santiago, Chile, about the Foreign Corrupt Practices Act (FCPA) and the necessity of having a Compliance Program.
  • Kathleen Kundar contributes a chapter on res judicata to International Aspects of U.S. Litigation, a two volume set recently published by the ABA.
  • Annie Borello Fiorilla speaks on legal issues triggered by corporate internationalization at the Italian Consulate in New York
  • David C. Camerini and Tomas M. Casalins publish article in Latin American jurisdictions titled “The (dis)advantages of being a US Person (residing outside the US)”.
  • Kenneth K. Yoon has been re-elected to the Board of Governors of the Korean American Lawyers Association of Greater New York
  • The Firm advises leading Ecuadorean company Favorita Group in obtaining a USD $102 million loan
  • Firm hosts Brazilian companies attending the 2015 Select USA Summit
  • The Firm sponsors American Arbitration Association conference on trade and access to justice
  • “Listing on the OTCQX” by Michael Hagan
  • Chinese lawyers hosted by the Firm
  • Michael Hagan discusses proposed crowdfunding regulations.

Contact Information

Fox Horan & Camerini LLP
885 Third Avenue
17th Floor
New York, NY 10022
(212) 480-4800

“Listing on the OTCQX” by Michael Hagan

 

OTCQX International Provides Access for U.S. Trading to Foreign Issuers

by Michael J. Hagan
October  2014

Non-U.S. companies are often eager to gain access to U.S. public markets to trade their securities and enhance both their liquidity and the company’s profile. At the same time, a number remain cautious and have concerns regarding the rigors of the registration process with the U.S. Securities and Exchange Commission (SEC) and the possible burdens and exposure associated with the ongoing reporting requirements under U.S. securities laws. Increasingly, non-U.S. companies that are traded on a qualified non-U.S. exchange have found OTCQX International a desirable route for accessing U.S. trading markets.

This article provides a brief overview of the key steps for qualified non-U.S. companies to “list” their securities for trading with U.S. investors.[1]

Click here for a copy of the article

 

[1] This note does not constitute formal legal advice and does not discuss all of the legal questions that a company must address to qualify its securities for trading on OTCQX International. Readers are advised to consult with their legal advisers. This note follows the convention of referring to quotation on OTCQX as a listing, even though the SEC does not consider OTCQX to constitute a securities exchange.

© 2022 Fox Horan & Camerini LLP
Privacy Policy

885 Third Avenue, 17th Floor  |  New York, NY 10022  |  T: (212) 480-4800  |  F: (212) 269-2383

Attorney Advertising Notice
Prior results do not guarantee a similar outcome. If you have any questions, for purposes of attorney advertising rules, please contact Fox Horan & Camerini LLP, 885 Third Avenue, 17th Floor, New York, NY 10022, (212) 480-4800.